Filing Details
- Accession Number:
- 0001385508-22-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-15 16:30:45
- Reporting Period:
- 2022-06-13
- Accepted Time:
- 2022-06-15 16:30:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385508 | Opiant Pharmaceuticals Inc. | OPNT | Pharmaceutical Preparations (2834) | 464744124 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1551246 | Michael Sinclair | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd, Suite 400 Santa Monica CA 90401 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-06-13 | 5,491 | $11.09 | 27,345 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-06-14 | 7,225 | $10.90 | 20,120 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-06-15 | 900 | $10.60 | 19,220 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |